A Potential New Alternative for Women with Menopausal Symptoms

MenoGeniX is a women’s health care company focused on the clinical development of a biopharmaceutical alternative to FDA-approved hormone therapies and anti-depressants to treat hot flashes and related vasomotor symptoms of menopause.

A Potential New Alternative for Women with Menopausal Symptoms

MenoGeniX is a women’s health care company focused on the clinical development of a biopharmaceutical alternative to FDA-approved hormone therapies and anti-depressants to treat hot flashes and related vasomotor symptoms of menopause.

A Potential New Alternative for Women with Menopausal Symptoms

MenoGeniX is a women’s health care company focused on the clinical development of a biopharmaceutical alternative to FDA-approved hormone therapies and anti-depressants to treat hot flashes and related vasomotor symptoms of menopause.

A Potential New Alternative for Women with Menopausal Symptoms

MenoGeniX is a women’s health care company focused on the clinical development of a biopharmaceutical alternative to FDA-approved hormone therapies and anti-depressants to treat hot flashes and related vasomotor symptoms of menopause.

About MenoGeniX

MenoGeniX is a privately-held, clinical stage biopharmaceutical company, dedicated to researching and developing a novel potential treatment for women suffering from hot flashes and related vasomotor symptoms of menopause.

Learn more about us...

Our Product: MNGX-100

MenoGeniX has completed a multi-site, double-blind, randomized, placebo-controlled Phase 1b clinical trial to evaluate the safety and effectiveness of MNGX-100 in treating hot flashes.

Learn more about us...

About Menopause

Over 10 million women in the US aged 50-65 experience hot flashes due to naturally-occurring menopause. Only two FDA approved medications are currently approved to treat the symptoms of menopause, hormone therapy and a low-dose form of the generic anti-depressant paroxetine. There is an unmet medical need for an alternative therapy for menopausal symptoms for women who are unwilling or unable to take the currently approved therapies.

Learn more about us...